शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
NEOGENNSENeogen Chemicals Limited· Chemicals & PetrochemicalsHighNeutral
Announced Wed, 11 Feb, 2026 · 20:10 IST

Board in-principle approval for preferential equity share issue

NEOGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.7%Reaction day
₹1295.00
prior close
₹1275.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.5%-0.2% vs market
Specialty Chemicals peers, median of 86sector-0.8%+0.1% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.1 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-1.0
15m
-1.2
30m
-1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.7-0.5-0.2-0.8+0.1
Next day
-1.7-2.0+0.3-2.0+0.3
2d
-1.1-2.7+1.5-3.4+2.3
3d
+0.4-1.7+2.1-3.1+3.5
4d
+2.3-1.4+3.8-2.9+5.2
5d
+3.9-2.8+6.7-3.6+7.5
1w
+7.0-2.8+9.9-4.3+11.3
15d
+2.4-8.4+10.8-10.2+12.5
1m
+11.7-9.1+20.8-9.6+21.3
2m
+6.5-4.0+10.5-6.5+13.0
3m
+26.6+2.6+24.0+1.5+25.1
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Neogen Chemicals Board has given in-principle approval to raise funds through a preferential issue of equity shares. Specifics on issue size, pricing, and allottees are not yet disclosed. Separately, Q3 FY26 standalone results show revenue of Rs 215.60 cr and PAT of Rs 8.77 cr; 9M FY26 standalone PAT was Rs 32.30 cr. Dahej fire insurance claim process continues.

Likely market impact

Existing shareholders may see equity dilution; details on size, price, and identity of allottees awaited.